Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Jaffe

Showing results (61-70 of 258) with videos related to

Pageof 26
Sort By:
Hematology/Oncology Clinics of North America|April 1, 1996
Hemolytic disorders associated with cancerM Rytting, L Worth, N Jaffe
Pediatric Radiology|January 1, 1987
Massive Wilms' tumor: sonographic demonstration of therapeutic response without alteration in sizeH Shimizu, N Jaffe, F Eftekhari
Journal of Neuro-Oncology|January 1, 1986
Metastatic epidural osteosarcoma initially diagnosed as cisplatin neuropathyH Shimizu, N Jaffe, E Kleinerman
The New England Journal of Medicine|December 28, 1972
Treatment of acute leukemiaE Frei, N Jaffe, S Farber
The American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine|January 1, 1971
Irradiation of the liver in children: acute effects enhanced by concomitant chemotherapeutic administration?M Tefft, A Mitus, N Jaffe
International Journal of Food Sciences and Nutrition|February 8, 2024
Time restricted eating and depression: a psychological perspectiveShalom N Jaffe, Eleanor L McGlinchey
Cancer Chemotherapy Reports|April 1, 1971
Evaluation of a combination of mitomycin C (NSC-26980), phenylalanine mustard (NSC-14210), and vincristine (NSC-67574) in the treatment of osteogenic sarcomaN Jaffe, D Traggis, C Enriquez
Cancer|December 1, 1994
Cisplatin-associated hemolytic uremic syndromeC Canpolat, P Pearson, N Jaffe
Cancer|April 15, 1996
Localized cisplatin hyperpigmentation induced by pressure. A case reportZ Al-Lamki, P Pearson, N Jaffe
Cancer Treatment Reports|April 1, 1987
Bleomycin, cyclophosphamide, and dactinomycin in metastatic osteosarcoma: lack of tumor regression in previously treated patientsC B Pratt, S Epelman, N Jaffe
Pageof 26

Showing results (61-70 of 258) with videos related to

Sort By:
Pageof 26
Hematology/Oncology Clinics of North America|April 1, 1996
Hemolytic disorders associated with cancerM Rytting, L Worth, N Jaffe
Pediatric Radiology|January 1, 1987
Massive Wilms' tumor: sonographic demonstration of therapeutic response without alteration in sizeH Shimizu, N Jaffe, F Eftekhari
Journal of Neuro-Oncology|January 1, 1986
Metastatic epidural osteosarcoma initially diagnosed as cisplatin neuropathyH Shimizu, N Jaffe, E Kleinerman
The New England Journal of Medicine|December 28, 1972
Treatment of acute leukemiaE Frei, N Jaffe, S Farber
The American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine|January 1, 1971
Irradiation of the liver in children: acute effects enhanced by concomitant chemotherapeutic administration?M Tefft, A Mitus, N Jaffe
International Journal of Food Sciences and Nutrition|February 8, 2024
Time restricted eating and depression: a psychological perspectiveShalom N Jaffe, Eleanor L McGlinchey
Cancer Chemotherapy Reports|April 1, 1971
Evaluation of a combination of mitomycin C (NSC-26980), phenylalanine mustard (NSC-14210), and vincristine (NSC-67574) in the treatment of osteogenic sarcomaN Jaffe, D Traggis, C Enriquez
Cancer|December 1, 1994
Cisplatin-associated hemolytic uremic syndromeC Canpolat, P Pearson, N Jaffe
Cancer|April 15, 1996
Localized cisplatin hyperpigmentation induced by pressure. A case reportZ Al-Lamki, P Pearson, N Jaffe
Cancer Treatment Reports|April 1, 1987
Bleomycin, cyclophosphamide, and dactinomycin in metastatic osteosarcoma: lack of tumor regression in previously treated patientsC B Pratt, S Epelman, N Jaffe
Pageof 26